Diabetes in Pregnancy

Textbook of Diabetes: Fourth Edition

Volumn , Issue , 2010, Pages 888-921

  Dornhorst, Anne ^a   Banerjee, Anita ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b Princess Royal University Hospital   (United Kingdom)

Author keywords

American Diabetic Association (ADA); Antenatal care in a diabetic p regnancy; Classification of diabetes in pregnancy; Clinical science and epidemiology of diabetes in pregnancy; Maturity onset diabetes of the young (MODY); Metabolic adaptation to pregnancy; Metabolic changes in pregnancy in women with diabetes; National Institute for Health and Clinical Excellence (NICE); Oral glucose tolerance test (OGTT); Risks of pregnancy for the mother with diabetes

Indexed keywords

EID: 79958184172     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444324808.ch53     Document Type: Chapter

References (405)

1. St. Vincent Declaration. Diabetic care and research in Europe. Diabet Med 1990; 7: 360.
2. Modder J, ed. Confidential Enquiry into Maternal and Child Health: Pregnancy in women with type 1 and type 2 diabetes in 2002-03, England, Wales and Northern Ireland. CEMACH: London, 2005.
3. Modder J, ed. Confidential Enquiry into Maternal and Child Health, Diabetes in Pregnancy: Are we providing the best care? Findings of a National Enquiry: England, Wales and Northern Ireland. CEMACH: London, 2007.
4. Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care 2008; 31: 1060-1079.
5. Guideline Development Group. Management of diabetes from preconception to the postnatal period: summary of NICE guidance. Br Med J 2008; 336: 714-717.
6. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. In: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
7. Buschard K, Buch I, Mølsted-Pedersen L, Hougaard P, Kühl C. Increased incidence of true type 1 diabetes acquired during pregnancy. Br Med J 1987; 294: 275-279.
8. Jarvela IY, Juutinen J, Koskela P, Hartikainen AL, Kulmala P, Knip M, et al. Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care 2006; 29: 607-612.
9. Cundy T, Gamble G, Neale L, Elder R, McPherson P, Henley P, et al. Differing causes of pregnancy loss in type 1 and type 2 diabetes. Diabetes Care 2007; 30: 2603-2607.
10. Saker PJ, Hattersley AT, Barrow B, Hammersley MS, McLellan JA, Lo YM, et al. High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population. Diabetologia 1996; 39: 1325-1328.
11. Ellard S, Beards F, Allen LI, Shepherd M, Ballantyne E, Harvey R, et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 2000; 43: 250-253.
12. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the Fifth International Workshop: Conference on Gestational Diabetes Mellitus. Diabetes Care 2007; 30 (Suppl 2): 251-260.
13. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002.
14. Lauenborg J, Grarup N, Damm P, Borch-Johnsen K, Jørgensen T, Pedersen O, et al. Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab 2009; 94: 145-150.
15. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999; 180: 903-916.
16. Lauenborg J, Hansen T, Jensen DM, Vestergaard H, Mølsted-Pedersen L, Hornnes P, et al. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 2004; 27: 1194-1199.
17. White P. Infants of mother with diabetes. Am J Med 1949; 7: 609-616.
18. Hare JW, White P. Gestational diabetes and the White classification. Diabetes Care 1980; 3: 394.
19. Pedersen J, Mølsted-Pedersen LM. Prognosis of the outcome of pregnancies in diabetics: a new classification. Acta Endocr 1965; 50: 70-78.
20. Lind T, Billewicz WZ, Brown G. A serial study of changes occurring in the oral glucose tolerance test during pregnancy. J Obstet Gynaecol Br Commonw 1973; 80: 1033-1039.
21. Mills JL, Jovanovic L, Knopp R, Aarons J, Conley M, Park E, et al. Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the diabetes in early pregnancy study. Metabolism 1998; 47: 1140-1144.
22. Spellacy WN, Goetz FC. Plasma insulin in normal late pregnancy. N Engl J Med 1963; 268: 988-991.
23. Cousins L. Insulin sensitivity in pregnancy. Diabetes 1991; 40 (Suppl 2): 39-43.
24. Lind T. Metabolic changes in pregnancy relevant to diabetes mellitus. Postgrad Med J 1979; 55: 353-357.
25. Buchanan TA, Metzger BE, Freinkel N, Bergman RN. Insulin sensitivity and ß-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990; 162: 1008-1114.
26. Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 1993; 264:E60-67.
27. Siman C, Eriksson U. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 1997; 46: 1054-1061.
28. Van Assche FA, Aerts L, De Prins F. A morphological study of the endocrine pancreas in human pregnancy. Br J Obstet Gynaecol 1978; 85: 818-820.
29. Bonner-Weir S. Perspective: Postnatal pancreatic beta cell growth. Endocrinology 2000; 141: 1926-1929.
30. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-110.
31. Freinkel N. Banting Lecture 1980: Of pregnancy and progeny. Diabetes 1980; 29: 1023-1035.
32. Sivan E, Homko CJ, Chen X, Reece EA, Boden G. Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes 1999; 48 (4): 834-838.
33. Homko CJ, Sivan E, Reece EA, Boden G. Fuel metabolism during pregnancy. Semin Reprod Endocrinol 1999; 17: 119-125.
34. Sivan E, Chen X, Homko CJ, Reece EA, Boden G. Longitudinal study of carbohydrate metabolism in healthy obese pregnant women. Diabetes Care 1997; 20: 1470-1475.
35. Metzger BE, Freinkel N. Accelerated starvation in pregnancy: implications for dietary treatment of obesity and gestational diabetes mellitus. Biol Neonate 1987; 51: 78-85.
36. Martin JW, Friesen HG. Effect of human placental lactogen on the isolated islets of Langerhans. Endocrinology 1969; 84: 619-622.
37. Handwerger S, Freemark M. Role of placental lactogen and prolactin in human pregnancy. Adv Exp Med Biol 1987; 219: 399-420.
38. Sivan E, Homko CJ, Whittaker PG, Reece EA, Chen X, Boden G. Free fatty acids and insulin resistance during pregnancy. J Clin Endocrinol Metab 1998; 83: 2338-2342.
39. Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab 2000; 13: 343-356.
40. Barbour LA, Shao J, Qiao L, Pulawa LK, Jensen DR, Bartke A, et al. Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynecol 2002; 186: 512-517.
41. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007; 30 (Suppl 2): 112-119.
42. Barbour LA, Mizanoor Rahman S, Gurevich I, Leitner JW, Fischer SJ, Roper MD, et al. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem 2005; 280: 37489-37494.
43. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207-2213.
44. Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 2006; 49: 1677-1685.
45. Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol 2006; 194: 1537-1545.
46. Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, Johansen M, Damm P, Mathiesen ER. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 2008; 31: 9-14.
47. Steel J, Johnstone FD, Hume R, Mao JH. Insulin requirements during pregnancy in women with type 1 diabetes. Obstet Gynecol 1994; 83: 253-258.
48. Felig P, Lynch V. Starvation in human pregnancy, hypoglycemia, hypoinsulinaemia and hyperketonaemia. Science 1970; 170: 990-992.
49. Kilvert JA, Nicholson HO, Wright AD. Ketoacidosis in diabetic pregnancy. Diabetes Med 1993; 10: 278-281.
50. Simmons D, Thompson CF, Conroy C, Scott DJ. Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care 2001; 24: 2078-2082.
51. Schneider MB, Umpierrez GE, Ramsey RD, Mabie WC, Bennett KA. Pregnancy complicated by diabetic ketoacidosis: maternal and fetal outcomes. Diabetes Care 2003; 26: 958-959.
52. Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med 2006; 144: 350-357.
53. Nicholls JS, Chan SP, Ali K, Beard RW, Dornhorst A. Insulin secretion and sensitivity in women fulfilling WHO criteria for gestational diabetes. Diabetic Med 1995; 12: 56-60.
54. Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner OF, et al. Pronounced insulin resisitance and inadequate ß-cell secretion characterizes lean gestational diabetes diabetes during and after pregnancy. Diabetes Care 1997; 20: 1717-1723.
55. Metzger BE, Phelps RL, Freinkel N, Navickas IA. Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids and individual amino acids. Diabetes Care 1980; 3: 402-409.
56. Nicholls JS, Ali K, Gray IP, Andres C, Niththyananthan R, Beard RW, et al. Increased maternal fasting proinsulin as a predictor of insulin requirement in women with gestational diabetes. Diabetes Med 1994; 11: 57-61.
57. Chan SP, Gelding SV, McManus RJ, Nicholls JS, Anyaoku V, Niththyananthan R, et al. Abnormalities of intermediate metabolism following a gestational diabetic pregnancy. Clin Endocrinol 1992; 36: 417-420.
58. Sakamaki H, Yamasaki H, Matsumoto K, Izumino K, Kondo H, Sera Y, et al. No deterioration in insulin sensitivity, but impairment of both pancreatic beta-cell function and glucose sensitivity, in Japanese women with former gestational diabetes mellitus. Diabet Med 1998; 15: 1039-1044.
59. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005; 115: 485-491.
60. Tura A, Mari A, Winzer C, Kautzky-Willer A, Pacini G. Impaired beta-cell function in lean normotolerant former gestational women with diabetes. Eur J Clin Invest 2006; 36: 22-28.
61. Tura A, Mari A, Prikoszovich T, Pacini G, Kautzky-Willer A. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes. Clin Endocrinol 2008; 69: 237-243.
62. Dornhorst A, Bailey PC, Anyaoku V, Elkeles RS, Johnston DG, Beard RW. Abnormalities of glucose tolerance following gestational diabetes. Q J Med 1990; 284: 1219-1228.
63. Buchanan TA, Kjos SL, Schafer U, Peters RK, Xiang A, Byrne J, et al. Utility of fetal measurements in the management of gestational diabetes mellitus. Diabetes Care 1998; 21 (Suppl 2): B99-106.
64. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Berkowitz K, Marroquin A, et al. Response of pancreatic ß-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes 2000; 49: 782-788.
65. O'Sullivan JB. Diabetes mellitus after GDM. Diabetes 1991; 40 (Suppl 2): 131-135.
66. Desoye G, Hofmann HH, Weiss PA. Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational women with diabetes treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects. Diabetologia 1992; 35: 45-55.
67. Weiss U, Cervar M, Puerstner P, Schmut O, Haas J, Mauschitz R, et al. Hyperglycaemia in vitro alters the proliferation and mitochondrial activity of the choriocarcinoma cell lines BeWo, JAR and JEG-3 as models for human first-trimester trophoblast. Diabetologia 2001; 44: 209-219.
68. Hiden U, Glitzner E, Ivanisevic M, Djelmis J, Wadsack C, Lang U, et al. MT1-MMP expression in first-trimester placental tissue is upregulated in type 1 diabetes as a result of elevated insulin and tumor necrosis factor-alpha levels. Diabetes 2008; 57: 150-157.
69. Hiden U, Glitzner E, Hartmann M, Desoye G. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. J Anat 2009; 215: 60-68.
70. Hiden U, Maier A, Bilban M, Ghaffari-Tabrizi N, Wadsack C, Lang I, et al. Insulin control of placental gene expression shifts from mother to foetus over the course of pregnancy. Diabetologia 2006; 491: 123-131.
71. Takayama-Hasumi S, Yoshino H, Shimisu M, Minei S, Sanaka M, Omori Y. Insulin-receptor kinase is enhanced in placentas from non-insulin-dependent women with diabetes with large-for-gestational-age babies. Diabetes Res Clin Pract 1994; 22: 107-116.
72. Walker A. Diabetes mellitus and pregnancy. Proc R Soc Med 1928; 21: 337-384.
73. Gabbe SG. A story of two miracles: the impact of the discovery of insulin on pregnancy in women with diabetes mellitus. Obstet Gynecol 1992; 79: 295-299.
74. Griffin ML, South SA, Yankov VI, Booth RA Jr, Asplin CM, Veldhuis JD, et al. Insulin-dependent diabetes mellitus and menstrual dysfunction. Ann Med 1994; 26: 331-340.
75. Danielson KK, Palta M, Allen C, D'Alessio DJ. The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes. J Clin Endocrinol Metab 2005; 90: 6466-6471.
76. Dorman JS, Steenkiste AR, Foley TP, Strotmeyer ES, Burke JP, Kuller LH, et al. Menopause in type 1 women with diabetes: is it premature? Diabetes 2001; 50: 1857-1862.
77. Engstrom I, Kroon M, Arvidsson CG, Segnestam K, Snellman K, Aman J. Eating disorders in adolescent girls with insulin-dependent diabetes mellitus: a population-based case-control study. Acta Paediatr 1999; 88: 175-180.
78. Goswami D, Conway GS. Premature ovarian failure. Horm Res 2007; 68: 196-202.
79. Buffington CK, Givens JR, Kitabchi AE. Enhanced adrenocortical activity as a contributing factor to diabetes in hyperandrogenic women. Metabolism 1994; 43: 584-590.
80. Morán C, Hernández E, Ruíz JE, Fonseca ME, Bermúdez JA, Zárate A. Upper body obesity and hyperinsulinemia are associated with anovulation. Gynecol Obstet Invest 1999; 47: 1-5.
81. Conn JJ, Jacobs HS. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol 2000; 52: 81-86.
82. Wright AD, Nicholson HO, Pollock A, Taylor KG, Betts S. Spontaneous abortion and diabetes mellitus. Postgrad Med J 1983; 59: 295-298.
83. Miodovnik M, Skillman C, Holroyde JC, Butler JB, Wendel JS, Siddiqi TA. Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion among insulin-dependent women with diabetes. Am J Obstet Gynecol 1985; 153: 439-442.
84. Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van Allen M, Aarons JH, et al. Incidence of spontaneous abortion among normal women and IDDM women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988; 319: 1617-1623.
85. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS. First trimester hemoglobin A1C and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 1989; 39: 225-231.
86. Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 1994; 84: 515-20.
87. Simpson JL, Mills JL, Holmes LB, Ober CL, Aarons J, Jovanovic L, et al. Low fetal loss rates after ultrasound-proved viability in early pregnancy. JAMA 1987; 258: 2555-2557.
88. Makrydimas G, Sebire NJ, Lolis D, Vlassis N, Nicolaides KH. Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation. Ultrasound Obstet Gynecol 2003; 22: 368-372.
89. Temple R, Aldridge V, Greenwood R, Heyburn P, Sampson M, Stanley K. Association between outcome of pregnancy and glycemic control in early pregnancy in type 1 diabetes: population based study. Br Med J 2002; 325: 1275-1276.
90. Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004; 19: 1644-1646.
91. Eriksson UJ. Congenital anomalies in diabetic pregnancy. Semin Fetal Neonatal Med 2009; 14: 85-93.
92. Bingham C, Hattersley AT. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. Nephrol Dial Transplant 2004; 19: 2703-2708.
93. Eriksson UJ. Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology 1988; 37: 365-374.
94. Kucera J. Rate and type of congenital anomalies among offspring of women with diabetes. J Reprod Med 1971; 7: 61-70.
95. Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glöckner E. Prevention of congenital malformations of infants of insulin-dependent mother with diabetes. Diabetes Care 1983; 6: 219-223.
96. Ylinen K. High maternal levels of hemoglobin A1c associated with delayed fetal lung maturation in insulin-dependent diabetic pregnancies. Acta Obstet Gynecol Scand 1987; 66: 263-266.
97. Mills JL, Knopp RH, Simpson JL, Jovanovic-Peterson L, Metzger BE, Holmes LB, et al. Lack of relation of increased malformation rates in infants of mother with diabetes to glycemic control during organogesis. N Engl J Med 1988; 318: 671-676.
98. Lucas JM, Leveno KJ, Williams ML, Raskin P, Whalley PJ. Early pregnancy glycosylated hemoglobin, severity of diabetes, and fetal malformations. Am J Obstet Gynecol 1989; 161: 426-431.
99. Hanson U, Persson B, Thunell S. The relationship between HbA1c in early pregnancy and the occurrence of spontaneous abortion and malformation in Sweden. Diabetologia 1990; 33: 100-104.
100. Hanson U, Persson B. Outcome of pregnancy complicated by type 1 insulin dependent diabetes in Sweden: acute pregnancy complica-tions, neonatal mortality, and morbidity. Am J Perinatol 1993; 10: 330-333.
101. Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, Ward Platt MP. Prospective population based survey of outcome of pregnancy in women with diabetes: results of the Northern Diabetic Pregnancy Audit, 1994. Br Med J 1997; 315: 279-281.
102. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO, et al. Outcomes of pregnancy in insulin dependent women with diabetes: results of a five year population cohort study. Br Med J 1997; 315: 275-278.
103. Reece EA, Homko CJ. Why do women with diabetes deliver malformed infants? Clin Obstet Gynecol 2000; 43: 32-45.
104. Suhonen L, Hiilesmaa V, Teramo K. Glycemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 2000; 43: 79-82.
105. Wender-Ozegowska E, Wróblewska K, Zawiejska A, Pietryga M, Szczapa J, Biczysko R. Threshold values of maternal blood glucose in early diabetic pregnancy: prediction of fetal malformations. Acta Obstet Gynecol Scand 2005; 84: 17-25.
106. Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. Br Med J 2006; 333: 177.
107. Mills JL, Baker L, Goldman AS. Malformations in infants of mother with diabetes occur before the seventh gestational week: implications for treatment. Diabetes 1979; 28: 292-293.
108. Martinez-Frias ML. Epidemiological analysis of outcomes of pregnancy in mother with diabetes: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 1994; 51: 108-113.
109. Mills JL. Malformations in infants of mother with diabetes. Teratology 1982; 25: 385-394.
110. Wren C, Birrell G, Hawthorne G. Cardiovascular malformations in infants of mother with diabetes. Heart 2003; 89: 1217-1220.
111. Otani H, Tanakao OH, Takewaki R, Naora H, Yoneyama T. Diabetic environment and genetic predisposition as causes of congenital malformations in NOD mouse embryos. Diabetes 1991; 40: 1245-1250.
112. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM. Hyperglycaemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 1998; 4: 1421-1424.
113. De Hertogh R, Vanderheyden I, Pampfer S, Robin D, Delcourt J. Maternal insulin treatment improves pre-implantation embryo development in diabetic rats. Diabetologia 1992; 35: 406-408.
114. Tonack S, Ramin N, Garimella S, Rao R, Seshagiri PB, Fischer B, et al. Expression of glucose transporter isoforms and the insulin receptor during hamster preimplantation embryo development. Ann Anat 2009; 191: 485-495.
115. Pampfer S, Vanderheyden I, Wuu YD, Baufays L, Maillet O, De Hertogh R. Possible role of TNF-a in early embryropathy associated with maternal diabetes in the rat. Diabetes 1995; 44: 531-536.
116. Eriksson UJ, Borg LA. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 1991; 34: 325-331.
117. Eriksson UJ, Borg LA. Diabetes and embryonic malformations: role of substrate-induced free-oxygen radical production for dysmorphogenesis in culture rat embryos. Diabetes 1993; 42: 411-419.
118. Wentzel P, Thunberg L, Eriksson UJ. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 1997; 40: 7-14.
119. Zaken V, Kohen R, Ornoy A. Vitamins C and E improve rat embryonic antioxidant defense mechanism in diabetic culture medium. Teratology 2001; 64: 33-44.
120. Wentzel P, Gareskog M, Eriksson U. Folic acid supplementation diminishes diabetes-and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes 2005; 54: 546-53.
121. Baker L, Piddington R, Goldman A, Egler J, Moehring J. Myoinositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos. Diabetologia 1990; 33: 593-596.
122. Akashi M, Akazawa S, Akazawa M, Trocino R, Hashimoto M, Maeda Y, et al. Effects of insulin and myo-inositol on embryo growth and development during early organogenesis in streptozotocin-induced diabetic rats. Diabetes 1991; 40: 1574-1579.
123. Goldman AS, Goto MP. Biochemical basis of the diabetic embryopathy. Isr J Med Sci 1991; 27: 469-477.
124. Strieleman PJ, Connors MA, Metzger BE. Phosphoinositide metabolism in the developing conceptus: effects of hyperglycemia and scyllo-inositol in rat embryo culture. Diabetes 1992; 41: 989-997.
125. Reece EA. Maternal fetal fuels, diabetic embryopathy: pathomechanisms and prevention. Semin Reprod Endocrinol 1999; 17: 183-194.
126. Akashi M, Akazawa S, Akazawa M, Trocino R, Hashimoto M, Maeda Y, et al. Effects of insulin and myo-inositol on embryo growth and development during early organogenesis in streptozocin-induced diabetic rats. Diabetes 1991; 40: 1574-1579.
127. Reece EA, Khandelwal M, Wu YK, Borenstein M. Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. Am J Obstet Gynecol 1997; 176: 536-539.
128. Hashimoto M, Akazawa S, Akazawa M, Akashi M, Yamamoto H, Maeda Y, et al. Effects of hyperglycaemia on sorbitol and myo-inositol contents of cultured embryos: treatment with aldose reductase inhibitor and myo-inositol supplementation. Diabetologia 1990; 33: 597-602.
129. Wentzel P, Wentzel CR, Gäreskog MB, Eriksson UJ. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. Teratology 2001; 63: 193-201.
130. Wentzel P, Welsh N, Eriksson UJ. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes 1999; 48: 813-820.
131. Pinter E, Reece EA, Leranth CZ, Garcia-Segura M, Hobbins JC, Mahoney MJ, et al. Arachidonic acid prevents hyperglycemia-associated yolk sac damage and embryopathy. Am J Obstet Gynecol 1986; 155: 691-702.
132. Schoenfeld A, Warchaizer S, Erman A, Hod M. Prostaglandin metabolism in the yolk sacs of normal and diabetic pregnancies. Early Pregnancy 1996; 2: 129-132.
133. Pani L, Horal M, Loeken MR. Polymorphic susceptibility to the molecular causes of neural tube defects during diabetic embryopathy. Diabetes 2002; 51: 2871-2874.
134. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001; 285: 2981-2986.
135. Kaplan JS, Iqbal S, England BG, Zawacki CM, Herman WH. Is pregnancy in women with diabetes associated with folate deficiency? Diabetes Care 1999; 22: 1017-1021.
136. Milner E, Hare JW, Clotherty JP. Elevated maternal haemoglobin A1c in early pregnancy and major congenital anomalies in infants of mother with diabetes. N Engl J Med 1981; 304: 1331-1334.
137. Goldman JA, Dicker D, Feldberg D, Yeshaya A, Samuel N, Karp M. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. Am J Obstet Gynecol 1986; 155: 293-297.
138. Steel JM, Johnstone FD, Hepburn DA, Smith AF. Can prepregnancy care of women with diabetes reduce the risk of abnormal babies? Br Med J 1990; 301: 1070-1074.
139. Kitzmiller JL, Gavin LA, Gin GD. Preconception management of diabetes continued through early pregnancy prevents the excess frequency of major congenital anomalies in infants of mother with diabetes. JAMA 1991; 265: 731-736.
140. Bell R, Bailey K, Cresswell T, Hawthorne G, Critchley J, Lewis-Barned D; Northern Diabetic Pregnancy Survey Steering Group. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. Br J Obstet Gynaecol 2008; 115: 445-452.
141. Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Moelsted-Pedersen L, Westergaard JG, et al. Peri-conceptional A1c and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 2009; 32: 1046-1048.
142. Diabetes Control and Complications Trial Research Group. Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol 1996; 174: 1343-1353.
143. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q J Med 2001; 94: 435-444.
144. Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 2007; 30: 1920-1925.
145. Simmons D, Robertson S. Influence of maternal insulin treatment with insulin on infants of mothers with gestational diabetes. Diabetes Med 1997; 14: 762-765.
146. Kerssen A, de Valk HW, Visser GH. Do HbA1c levels and the selfmonitoring of blood glucose levels adequately reflect glycemic control during pregnancy in women with type 1 diabetes mellitus? Diabetologia 2006; 49: 25-28.
147. Piper K, Brickwood S, Turnpenny LW, Cameron IT, Ball SG, Wilson DI, et al. Beta cell differentiation during early human pancreas development. J Endocrinol 2004; 181: 11-23.
148. Schwartz R, Gruppuso PA, Petzold K, Brambilla D, Hiilesmaa V, Teramo KA. Hyperinsulinemia and macrosomia in the fetus of the mother with diabetes. Diabetes Care 1994; 17: 640-648.
149. Carpenter MW, Canick JA, Hogan JW, Shellum C, Somers M, Star JA. Amniotic fluid insulin at 14-20 weeks'gestation: association with later maternal glucose intolerance and birth macrosomia. Diabetes Care 2001; 24: 1259-1263.
150. Veening MA, van Weissenbruch MM, Heine RJ, Delemarre-van de Waal HA. Beta-cell capacity and insulin sensitivity in prepubertal children born small for gestational age: influence of body size during childhood. Diabetes 2003; 52: 1756-1760.
151. Mericq V, Ong KK, Bazaes R, Peña V, Avila A, Salazar T, et al. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small-and appropriate-for-gestational-age children. Diabetologia 2005; 48: 2609-2614.
152. Simmons RA. Developmental origins of beta-cell failure in type 2 diabetes: the role of epigenetic mechanisms. Pediatr Res 2007; 61: 64R-67R.
153. Boloker J, Gertz SJ, Simmons RA. Gestational diabetes leads to the development of diabetes in adulthood in the rat. Diabetes 2002; 51: 1499-1506.
154. Gatford KL, Mohammad SN, Harland ML, De Blasio MJ, Fowden AL, Robinson JS, et al. Impaired beta-cell function and inadequate compensatory increases in beta-cell mass after intrauterine growth restriction in sheep. Endocrinology 2008; 149: 5118-5127.
155. Simmons RA. Developmental origins of adult disease. Pediatr Clin North Am 2009; 56: 449-466.
156. Verhaeghe J, van Bree R, Van Herck E. Maternal body size and birth weight: can insulin or adipokines do better? Metabolism 2006; 55: 339-344.
157. Hay WW. The role of placental-fetal interaction in fetal nutrition. Semin Perinatol 1991; 15: 424-433.
158. Bradley RJ, Nicolaides KH, Brudenell JM. Are all infants of mother with diabetes "macrosomic" ? Br Med J 1988; 297: 1583-1585.
159. Johnstone FD, Lindsay RS, Steel J. Type 1 diabetes and pregnancy: trends in birth weight over 40 years at a single clinic. Obstet Gynecol 2006; 107: 1297-1302.
160. Boyd M, Usher RH, McLean FH. Fetal macrosomia: prediction, risk, proposed management. Obstet Gynecol 1983; 61: 715-722.
161. Spellacy WN, Miller S, Winegar A, Peterson PQ. Macrosomia: maternal characteristics and infant complications. Obstet Gynecol 1985; 66: 158-161.
162. Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R, Van Assche FA. C-peptide, insulin-like growth factors I and II, and insulin -like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol 1993; 169: 89-97.
163. Schwartz R, Susa J. Fetal macrosomia-animal models. Diabetes Care 1980; 3: 430-432.
164. Pedersen B. Hyperglycaemia-hyperinsulinism theory and birthweight. In: Pedersen J, ed. The Pregnant Diabetic and her Newborn: Problems and Management. Baltimore MD: Williams & Wilkins, 1977: 211-220.
165. Cano A, Barcelo F, Fuente T, Martinez P, Parrilla JJ, Abad L. Relationship of maternal glycosylated hemoglobin and fetal beta-cell activity with birth weight. Gynecol Obstet Invest 1986; 22: 91-96.
166. Metzger BE. Biphasic effect of maternal metabolism on fetal growth: quintessential expression of fuel-mediated teratogenesis. Diabetes 1991; 40 (Suppl 2): 99-105.
167. Challier JC, Schneider H, Dancic J. I n vitro perfusion of human placenta. V. Oxygen consumption. Am J Obstet Gynecol 1976; 126: 261-265.
168. Buchanan TA, Kjos SL, Montoro MN, Wu PY, Madrilejo NG, Gonzalez M, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994; 17: 275-283.
169. Lauszus FF, Grøn PL, Klebe JG. Pregnancies complicated by diabetic proliferative retinopathy. Acta Obstet Gynecol Scand 1998; 77: 814-818.
170. Rey E, Attie C, Bonin A. The effects of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol 1999; 181: 202-206.
171. Katz AI, Lindheimer MD, Mako ME, Rubenstein AH. Peripheral metabolism of insulin, proinsulin, and C-peptide in the pregnant rat. J Clin Invest 1975; 56: 1608-1614.
172. Sosenko IR, Kitzmiller JL, Loo SW, Blix P, Rubenstein AH, Gabbay KH. The infant of the mother with diabetes: correlation of increased cord blood C-peptide levels with macrosomia and hypoglycemia. N Engl J Med 1979; 301: 859-862.
173. Ogata ES, Freinkel N, Metzger BE, Phelps RL, Depp R, Boehm JJ, et al. Perinatal islet function in gestational diabetes: assessment by cord plasma C-peptide and amniotic fluid insulin. Diabetes Care 1980; 3: 425-429.
174. Sosenko JM, Kitzmiller JL, Fluckiger R, Loo SW, Younger DM, Gabbay KH. Umbilical cord glycosylated hemoglobin in infants of mother with diabetes: relationships to neonatal hypoglycemia, macrosomia, serum C-peptide. Diabetes Care 1982; 5: 566-570.
175. Lin CC, Moawad AH, River P, Blix P, Abraham M, Rubenstein AH. Amniotic fluid C-peptide as an index for intrauterine fetal growth. Am J Obstet Gynecol 1981; 139: 390-396.
176. Lin CC, River P, Moawad AH, Lowensohn RI, Blix PM, Abraham M, et al. Prenatal assessment of fetal outcome by amniotic fluid C-peptide levels in pregnant women. Am J Obstet Gynecol 1981; 141: 671-677.
177. Dornhorst A, Nicholls JSD, Ali K, Andres C, Adamson DL, Kelly LF, et al. Fetal proinsulin and birth weight. Diabet Med 1994; 11: 171-181.
178. Teramo K, Kari MA, Eronen M, Markkanen H, Hiilesmaa V. High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies. Diabetologia 2004; 47: 1695-1703.
179. Susa JB, Gruppuso PA, Widness JA, Domenech M, Clemons GK, Sehgal P, et al. Chronic hyperinsulinemia in the fetal rhesus monkey: effects of physiologic hyperinsulinemia on fetal substrates, hormones, and hepatic enzymes. Am J Obstet Gynecol 1984; 150: 415-420.
180. Philipps AF, Rosenkrantz TS, Clark RM, Knox I, Chaffin DG, Raye JR. Effects of fetal insulin deficiency on growth in fetal lambs. Diabetes 1991; 40: 20-27.
181. Woods KA, Camacho-Hübner C, Barter D, Clark AJ, Savage MO. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr Suppl 1997; 423: 39-45.
182. Gluckman PD. The endocrine role of fetal growth in late gestation: the role of insulin-like growth factors. J Clin Endocrinol Metab 1995; 80: 1047-1050.
183. Vatten LJ, Nilsen ST, Odegård RA, Romundstad PR, Austgulen R. Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term. Pediatrics 2002; 109: 1131-1135.
184. Byun D, Mohan S, Kim C, Suh K, Yoo M, Lee H, et al. Studies on human pregnancy-induced insulin-like growth factor (IGF)-binding protein-4 proteases in serum: determination of IGF-II dependency and localization of cleavage site. J Clin Endocrinol Metab 2000; 85: 373-381.
185. Lindsay RS, Westgate JA, Beattie J, Pattison NS, Gamble G, Mildenhall LF, et al. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes. Clin Endocrinol 2007; 66: 322-328.
186. Silver RM, Varner MW, Reddy U, Goldenberg R, Pinar H, Conway D, et al. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol 2007; 196: 433-444.
187. Lauenborg J, Mathiesen E, Ovesen P, Westergaard JG, Ekbom P, Mølsted-Pedersen L, et al. Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care 2003; 26: 1385-1389.
188. Karlsson K, Kjellmer I. The outcome of diabetic pregnancies in relationship to the mother's blood sugar level. Am J Obstet Gynecol 1972; 112: 213-220.
189. Stephansson O, Dickman PW, Johansson A, Cnattingius S. Maternal weight, pregnancy weight gain, and the risk of antepartum stillbirth. Am J Obstet Gynecol 2001; 184: 463-469.
190. Cnattingius S, Stephansson O. The epidemiology of stillbirth. Semin Perinatol 2002; 26: 25-30.
191. Cundy T, Gamble G, Townend K, Henley PG, MacPherson P, Roberts AB. Perinatal mortality in type 2 diabetes mellitus. Diabet Med 2000; 17: 33-39.
192. Teramo KA, Widness JA. Increased fetal plasma and amniotic fluid erythropoietin concentrations: markers of intrauterine hypoxia. Neonatology 2009; 95: 105-116.
193. Milley JR, Papacostas JS. Effect of insulin on metabolism of fetal sheep hindquarters. Diabetes 1989; 38: 597-603.
194. Myers RE. Brain damage due to asphyxia: mechanism of causation. J Perinat Med 1981; 9: 78-86.
195. Philips AF, Dubin JW, Matty PJ, Raye JR. Arterial hypoxemia and hyperinsulinemia in the chronically hyperglycemic fetal lamb. Pediatr Res 1982; 16: 653-658.
196. Bradley RJ, Brudenell JM, Nicolaides KH. Fetal acidosis and hyperlacticaemia diagnosed by cordocentesis in pregnancies complicated by maternal diabetes mellitus. Diabet Med 1991; 8: 464-468.
197. Fraser RB, Bruce C. Amniotic fluid insulin levels identify the fetus at risk of neonatal hypoglycemia. Diabet Med 1999; 16: 568-572.
198. Williams AF. Hyoglycaemia of the newborn: a review. Bull World Health Organ 1997; 75: 261-290.
199. Hawdon JM. Hypoglycemia in newborn infants: defining the features associated with adverse outcomes-a challenging remit. Biol Neonate 2006; 90: 87-88. [Commentary to Rozance PJ, Hay WW. Hypoglycemia in newborn infants: features associated with adverse outcomes. Biol Neonate 2006; 90:74-86.]
200. Cornblath M, Hawdon JM, Williams AF, Aynsley-Green A, Ward-Platt MP, Schwartz R, et al. Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics 2000; 105: 1141-1145.
201. Hawdon JM, Ward Platt MP, Aynsley-Green A. Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Arch Dis Child 1992; 67: 357-365.
202. Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycemia. Br Med J 1988; 297: 1304-1308.
203. Beard AG, Panos TC, Marasigan BV, Eminians J, Kennedy HF, Lamb J. Perinatal stress and the premature neonate. II. Effect of fluid and calorie deprivation on blood glucose. J Pediatr 1966; 68: 329-343.
204. Mimouni F, Tsang RC, Hertzberg VS, Miodovnik M. Polycythemia, hypomagnesemia, and hypocalcemia in infants of mother with diabetes. Am J Dis Child 1986; 140: 798-800.
205. Widness JA, Susa JB, Garcia JF, Singer DB, Sehgal P, Oh W, et al. Increased erythropoiesis and elevated erythropoietin in infants born to mother with diabetes in hyperinsulinemic rhesus fetuses. J Clin Invest 1981; 67: 637-642.
206. Salvesen DR, Brudenell JM, Snijders RJ, Ireland RM, Nicolaides KH. Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 1993; 168: 88-94.
207. Mimouni F, Miodovnik M, Whitsett JA, Holroyde JC, Siddiqi TA, Tsang RC. Respiratory distress syndrome in infants of mother with diabetes in the 1980s: no direct adverse effect of maternal diabetes with modern management. Obstet Gynecol 1987; 69: 191-195.
208. Gutgesell HP, Speer ME, Rosenberg HS. Characterization of the cardiomyopathy in infants of mother with diabetes. Circulation 1980; 61: 441-450.
209. Zielinsky P. Role of prenatal echocardiography in the study of hypertrophic cardiomyopathy in the fetus. Echocardiography 1991; 8: 661-668.
210. Hawa MI, Beyan H, Buckley LR, Leslie RD. Impact of genetic and non-genetic factors in type 1 diabetes. Am J Med Genet 2002; 115: 8-17.
211. Ridderstrale M, Groop L. Genetic dissection of type 2 diabetes. Mol Cell Endocrinol 2009; 297: 10-17.
212. Pettitt D, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC. Congenital susceptibility to NIDDM: role of intrauterine environment. Diabetes 1988; 37: 622-628.
213. Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000; 49: 2208-2211.
214. Weiss PA, Scholz HS, Haas J, Tamussino KF. Effect of fetal hyperinsulinism on oral glucose tolerance test results in patients with gestational diabetes mellitus. Am J Obstet Gynecol 2001; 184: 470-475.
215. Sobngwi E, Boudou P, Mauvais-Jarvis F, Leblanc H, Velho G, Vexiau P, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 2003; 361: 1861-1865.
216. Clausen TD, Mathiesen ER, Hansen T, Pedersen O, Jensen DM, Lauenborg J, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008; 31: 340-346.
217. Martin A, Simpson JL, Ober C, Freinkel N. Frequency of diabetes mellitus in mothers of probands with gestational diabetes: possible maternal influence on the predisposition to gestational diabetes. Am J Obstet Gynecol 1985; 151: 471-475.
218. Alcolado JC, Laji K, Gill-Randall R. Maternal transmission of diabetes. Diabet Med 2002; 19: 89-98.
219. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Type 2 diabetes in Asian-Indian urban children. Diabetes Care 2003; 26: 1022-1025.
220. Dabelea D, Knowler WC, Pettitt DJ. Effect of diabetes in pregnancy on offspring: follow-up research in the Pima Indians. J Matern Fetal Med 2000; 9: 83-88.
221. Gautier JF, Wilson C, Weyer C, Mott D, Knowler WC, Cavaghan M, et al. Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. Diabetes 2001; 50: 1828-1833.
222. Eriksson M, Wallander MA, Krakau I, Wedel H, Svärdsudd K. Birth weight and cardiovascular risk factors in a cohort followed until 80 years of age: the study of men born in 1913. J Intern Med 2004; 255: 236-246.
223. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Ckark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-67.
224. Gill-Randall R, Adams D, Ollerton RL, Lewis M, Alcolado JC. Type 2 diabetes mellitus: genes or intrauterine environment? An embryo transfer paradigm in rats. Diabetologia 2004; 47: 1354-1359.
225. Temple RC, Aldridge VA, Sampson MJ, Greenwood RH, Heyburn PJ, Glenn A. Impact of pregnancy on the progression of diabetic retinopathy in type 1 diabetes. Diabet Med 2001; 18: 573-577.
226. Rahman W, Rahman FZ, Yassin S, Al-Suleiman SA, Rahman J. Progression of retinopathy during pregnancy in type 1 diabetes mellitus. Clin Experiment Ophthalmol 2007; 35: 231-236.
227. Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 2000; 23: 1084-1091.
228. Arun CS, Taylor R. Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes. Diabetologia 2008; 51: 1041-1045.
229. Larsen M, Colmorn LB, Bønnelycke M, Kaaja R, Immonen I, Sander B, et al. Retinal artery and vein diameters during pregnancy in women with diabetes. Invest Ophthalmol Vis Sci 2005; 46: 709-713.
230. Loukovaara S, Immonen I, Koistinen R, Rudge J, Teramo KA, Laatikainen L, et al. Angiopoietic factors and retinopathy in pregnancies complicated with type 1 diabetes. Diabet Med 2004; 21: 697-704.
231. Loukovaara S, Immonen I, Koistinen R, Hiilesmaa V, Kaaja R. Inflammatory markers and retinopathy in pregnancies complicated with type I diabetes. Eye 2005; 19: 422-430.
232. Kaaja R, Loukovaara S. Progression of retinopathy in type 1 women with diabetes during pregnancy. Curr Diabetes Rev 2007; 3: 85-93.
233. Loukovaara S, Immonen IR, Loukovaara MJ, Koistinen R, Kaaja RJ. Glycodelin: a novel serum anti-inflammatory marker in type 1 diabetic retinopathy during pregnancy. Acta Ophthalmol Scand 2007; 85: 46-49.
234. Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanovic-Peterson L, Knopp RH, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care 1995; 18: 631-637.
235. Rosenn B, Miodovnik M, Kranias G, Khoury J, Combs CA, Mimouni F, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol 1992; 166: 1214-1218.
236. Arun CS, Al-Bermani A, Stannard K, Taylor R. Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age population. Diabet Med 2009; 26: 489-492.
237. Kitzmiller JL, Combs CA. Management amd outcome of pregnancy complicated by diabetic nephropathy. In: Dornhorst A, Hadden DR, eds. Diabetes and Pregnancy: an International Approach to Diagnosis and Management. Chichester, UK: John Wiley & Sons Ltd, 1996: 167-206.
238. Dunne FP, Chowdhury TA, Hartland A, Smith T, Brydon PA, McConkey C, et al. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy. Q J Med 1999; 92: 451-454.
239. Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Mølvig J, Mathiesen ER. Pregnancy outcome in type 1 women with diabetes with microalbuminuria. Diabetes Care 2001; 24: 1739-1744.
240. Nielsen LR, Müller C, Damm P, Mathiesen ER. Reduced prevalence of early preterm delivery in women with type 1 diabetes and micro-albuminuria: possible effect of early antihypertensive treatment during pregnancy. Diabet Med 2006; 23: 426-431.
241. Nielsen LR, Damm P, Mathiesen ER. Improved pregnancy outcome in type 1 women with diabetes with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 2009; 32: 38-44.
242. Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Jensen DM, Mathiesen ER. Elevated third-trimester haemoglobin A1c predicts preterm delivery in type 1 diabetes. J Diabetes Complications 2008; 22: 297-302.
243. Sorensen VR, Mathiesen ER, Heaf J, Feldt-Rasmussen B. Improved survival rate in patients with diabetes and end-stage renal disease in Denmark. Diabetologia 2007; 50: 922-929.
244. Rossing K, Jacobsen P, Hommel E, Mathiesen E, Svenningsen A, Rossing P, et al. Pregnancy and progression of diabetic nephropathy. Diabetologia 2002; 45: 36-41.
245. Khoury JC, Miodovnik M, LeMasters G, Sibai B. Pregnancy outcome and progression of diabetic nephropathy: what's next? J Matern Fetal Neonatal Med 2002; 11: 238-244.
246. Biesenbach G, Grafinger P, Zazgornik J, Helmut, Stöger. Perinatal complications and three-year follow up of infants of mother with diabetes with diabetic nephropathy stage IV. Ren Fail 2000; 22: 573-580.
247. Ogburn PL, Kitzmiller JL, Hare JW, Phillippe M, Gabbe SG, Miodovnik M, et al. Pregnancy following renal transplantation in class T diabetes mellitus. JAMA 1986; 255: 911-915.
248. McKay DB, Josephson MA. Pregnancy in recipients of solid organs: effects on mother and child. N Engl J Med 2006; 354: 1281-1293.
249. Sibanda N, Briggs JD, Davison JM, Johnson RJ, Rudge CJ. Pregnancy after organ transplantation: a report from the UK Transplant pregnancy registry. Transplantation 2007; 83: 1301-1307.
250. Sgro MD, Barozzino T, Mirghani HM, Sermer M, Moscato L, Akoury H, et al. Pregnancy outcome post renal transplantation. Teratology 2002; 65: 5-9.
251. Simchen MJ, Yinon Y, Moran O, Schiff E, Sivan E. Pregnancy outcome after age 50. Obstet Gynecol 2006; 108: 1084-1088.
252. Ladner HE, Danielsen B, Gilbert WM. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol 2005; 105: 480-484.
253. Lewis G, ed. Confidential Enquiry into Maternal and Child Health (CEMACH). The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers'Lives: reviewing maternal deaths to make motherhood safer, 2003-2005. London: CEMACH, 2007.
254. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol 2008; 5 2: 171-180.
255. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. A nn Intern Med 1996; 1 25: 751-762.
256. Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 2007; 147: 149-155.
257. Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB Sr, Savage PJ, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009; 119: 1728-1735.
258. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the UK: a cohort study using the general practice research database. Diabetes Care 2006; 29: 798-804.
259. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA, et al. Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database. Diabetologia 2008; 51: 1639-1645.
260. Dale AC, Nilsen TI, Vatten L, Midthjell K, Wiseth R. Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74,914 individuals in the HUNT 1 Study. Eur Heart J 2007; 28: 2924-2929.
261. Heslehurst N, Lang R, Rankin J, Wilkinson JR, Summerbell CD. Obesity in pregnancy: a study of the impact of maternal obesity on NHS maternity services. Br J Obstet Gynaecol 2007; 114: 334-342.
262. Heslehurst N, Ells LJ, Simpson H, Batterham A, Wilkinson J, Summerbell CD. Trends in maternal obesity incidence rates, demographic predictors, and health inequalities in 36,821 women over a 15-year period. Br J Obstet Gynaecol 2007; 114: 187-194. 263 Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA.
263. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics 2003; 111: 1152-1158.
264. Rajasingam D, Seed PT, Briley AL, Shennan AH, Poston L. A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese women. Am J Obstet Gynecol 2009; 200: 395,e1-9.
265. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25: 1175-1182.
266. Jolly MC, Sebire NJ, Harris JP, Regan L, Robinson S. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol 2003; 111: 9-14.
267. Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 2009; 32: 1076-1080.
268. Richards ID. Congenital malformations and environmental influences in pregnancy. Br J Prev Soc Med 1969; 23: 218-225.
269. García-Patterson A, Erdozain L, Ginovart G, Adelantado JM, Cubero JM, Gallo G, et al. In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes. Diabetologia 2004; 47: 509-514.
270. Moore LL, Bradlee ML, Singer MR, Rothman KJ, Milunsky A. Chromosomal anomalies among the offspring of women with gestational diabetes. Am J Epidemiol 2002; 155: 719-724.
271. Martinez-Frias ML, Frías JP, Bermejo E, Rodríguez-Pinilla E, Prieto L, Frías JL. Pre-gestational maternal body mass index predicts an increased risk of congenital malformations in infants of mothers with gestational diabetes. Diabet Med 2005; 22: 775-781.
272. Lazarus JH, Premawardhana LD. Screening for thyroid disease in pregnancy. J Clin Pathol 2005; 58: 449-452.
273. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-555.
274. Campbell NR, Hasinoff BB, Stalts H, Rao B, Wong NC. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 1992; 117: 1010-1013.
275. Lazarus JH. Thyroid disorders associated with pregnancy: etiology, diagnosis, and management. Treat Endocrinol 2005; 4: 31-41.
276. Pearson DW, Kernaghan D, Lee R, Penney GC; Scottish Diabetes in Pregnancy Study Group. The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes mellitus. Br J Obstet Gynaecol 2007; 114: 104-107.
277. Elixhauser A, Kitzmiller JL, Weschler JM. Short-term cost benefit of pre-conception care for diabetes. Diabetes Care 1996; 19: 384.
278. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. Br Med J 2004; 328: 915.
279. Janz NK, Herman WH, Becker MP, Charron-Prochownik D, Shayna VL, Lesnick TG, et al. Diabetes and pregnancy: factors associated with seeking pre-conception care. Diabetes Care 1995; 18: 157-165.
280. Holing EV. Preconception care of women with diabetes: the unrevealed obstacles. J Matern Fetal Med 2000; 9: 10-13.
281. Steel JM. Personal experience of prepregnancy care in women with insulin dependent diabetes. Aust N Z J Obstet Gynaecol 1994; 34: 135-139.
282. Dunne FP, Brydon P, Smith T, Essex M, Nicholson H, Dunn J. Pre-conceptive diabetes care in insulin dependent diabetes mellitus. Q J Med 1999; 92: 175-176.
283. Gibb D, Hockey S, Brown LJ, Lunt H. Attitudes and knowledge regarding contraception and prepregnancy counselling in insulin dependent diabetes. N Z Med J 1994; 107: 484-486.
284. Holing EV, Beyer CS, Brown ZA, Connell FA. Why don't women with diabetes plan their pregnancies? Diabetes Care 1998; 21: 889-893.
285. Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 2006; 29: 1744-1749.
286. McElduff A, Cheung NW, McIntyre HD, Lagström JA, Oats JJ, Ross GP, et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med J Aust 2005; 183: 373-377.
287. Rosenn BM, Miodovnik M, Holcberg G, Khoury JC, Siddiqi TA. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995; 85: 417-422.
288. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. Br Med J 2002; 325: 746-749.
289. MRC Vitamin Research Study Group. Prevention of neural tube defects: the results of the Medical Research Council Vitamin Study. Lancet 1991; 388: 131-137.
290. Rogers I, Emmett P. Diet during pregnancy in a population of pregnant women in South West England. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Eur J Clin Nutr 1998; 52: 246-250.
291. Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ. The role of modifiable pre-pregnancy risk factors in preventing adverse fetal outcomes among women with type 1 and type 2 diabetes. Acta Obstet Gynecol Scand 2009; 88: 1153-1157.
292. McDermott R, Campbell S, Li M, McCulloch B. The health and nutrition of young indigenous women in north Queensland: intergenerational implications of poor food quality, obesity, diabetes, tobacco smoking and alcohol use. Public Health Nutr 2009; 12: 2143-2149.
293. Kiel D, Dodson EA, Artal R, Boehmer TK, Leet TL. Gestational weight gain and pregnancy outcomes in obese women: how much is enough? Obstet Gynecol 2007; 110: 752-758.
294. Rasmussen K, Yaktine A, eds. Weight Gain During Pregnancy: Reexamining the Guidelines in Committee to Reexamine Institute of Medicine Pregnancy Weight Guidelines. Institute of Medicine; National Research Council. Washington, DC: National Academies Press, 2009.
295. Reisenberger K, Egarter C, Sternberger B, Eckenberger P, Eberle E, Weissenbacher ER. Placental passage of angiotensin-converting enzyme inhibitors. Am J Obstet Gynecol 1996; 174: 1450-1455.
296. Steffensen FH, Steffensen FH, Olesen C, Nielsen GL, Pedersen L, Olsen J. Pregnancy outcome with ACE-inhibitor use in early pregnancy. Lancet 1998; 351: 596.
297. Lip GYH, Churchill D, Beevers M, Auckett A, Beevers DG. Angiotensin-converting-enzyme inhibitors in early pregnancy. Lancet 1997; 350: 1446-1447.
298. Bar J, Chen R, Schoenfeld A, Orvieto R, Yahav J, Ben-Rafael Z, et al. Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy. J Pediatr Endocrinol 1999; 12: 659-665.
299. Burrows RF, Burrows EA. Assessing the teratogenic potential of angiotensin-converting enzyme inhibitors in pregnancy. Aust N Z J Obstet Gynaecol 1998; 38: 306-311.
300. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443-2451.
301. Saji H, Yamanaka M, Hagiwara A, Ijiri R. Losartan and fetal toxic effects. Lancet 2001; 357: 363.
302. Gersak K, Cvijic M, Cerar L. Angiotensin II receptor blockers in pregnancy: a report of five cases. Reprod Toxicol 2009; 28: 109-112.
303. Briggs G, Freeman RA, Yaffe S. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 7th edn. Philadelphia, PA: Lippincott, Williams and Wilkins, 2007.
304. Joint Formulary Committee. British National Formulary, Vol. 53. London: British Medical Association and Royal Pharmaeutical Society of Great Britain, 2007.
305. Edison RJ, Muenke M. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 2004; 350: 1579-1582.
306. Belfort MA, Anthony J, Buccimazza A, Davey DA. Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension. O bstet Gynecol 1990; 7 5: 970-974.
307. Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L, et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996; 174: 823-828.
308. Chan WC, Lim LT, Quinn MJ, Knox FA, McCance D, Best RM. Management and outcome of sight-threatening diabetic retinopathy in pregnancy. Eye 2004; 18: 826-832.
309. Greco L, Veneziano A, Di Donato L, Zampella C, Pecorano M, Paladini D, e t al. Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy. Gut 2004; 53: 149-151.
310. Hare JW. Medical management. In: Hare JW, ed. Diabetes Complicating Pregnancy: The Joslin Clinic Method. New York: Alan R. Liss, 1989: 35-51.
311. Langer O, Anyaegbunam A, Brustman L, Guidetti D, Levy J, Mazze R. Pregestational diabetes: insulin requirements throughout pregnancy. Am J Obstet Gynecol 1988; 159: 616-621.
312. Jovanovic L, Knopp RH, Brown Z, Conley MR, Park E, Mills JL, et al. Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care 2001; 24: 1130-1136.
313. Rosenn B, Miodovnik M, Khoury JC, Siddiqi TA. Counterregulatory hormonal responses to hypoglycemia during pregnancy. Obstet Gynecol 1996; 87: 568-574.
314. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003; 26: 1902-1912.
315. Hellmuth E, Damm P, Mølsted-Pedersen L, Bendtson I. Prevalence of nocturnal hypoglycemia in first trimester of pregnancy in patients with insulin treated diabetes mellitus. Acta Obstet Gynecol Scand 2000; 79: 958-962.
316. Murphy HR, Rayman G, Duffield K, Lewis KS, Kelly S, Johal B, et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care 2007; 30: 2785-2791.
317. Leinonen PJ, Hiilesmaa VK, Kaaja RJ, Teramo KA. Maternal mortality in type 1 diabetes. Diabetes Care 2001; 24: 1501-1502.
318. Manderson JG, Patterson CC, Hadden DR, Traub AI, Ennis C, McCance DR. Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. Am J Obstet Gynecol 2003; 189: 507-512.
319. DeVeciana M, Major CA, Morgan MA. Postprandial verses preprandial glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995; 333: 1237-1241.
320. Yogev Y, Chen R, Ben-Haroush A, Phillip M, Jovanovic L, Hod M. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol 2003; 101: 633-638.
321. Kerssen A, de Valk HW, Visser GH. Forty-eight-hour first-trimester glucose profiles in women with type 1 diabetes mellitus: a report of three cases of congenital malformation. Prenat Diagn 2006; 26: 123-127.
322. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. Br Med J 2008; 337:a1680.
323. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477-2486.
324. Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus-how tight is tight enough: small for gestational age versus large for gestational age? A m J Obstet Gynecol 1989; 1 61: 646-653.
325. Nachum Z, Ben-Shlomo I, Weiner E, Shalev E. Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. Br Med J 1999; 319: 1223-1227.
326. Plank J, Siebenhofer A, Berghold A, Jeitler K, Horvath K, Mrak P, et al. Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus. Arch Intern Med 2005; 165: 1337-1344.
327. Mathiesen ER, Kinsley B, Amiel SA, Heller S, McCance D, Duran S, et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007; 30: 771-776.
328. Jovanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999; 22: 1422-1427.
329. Persson B, Swahn ML, Hjertberg R, Hanson U, Nord E, Nordlander E, et al. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Res Clin Pract 2002; 58: 115-121.
330. Aydin Y, Berker D, Direktör N, Ustün I, TütüncüYA, Iik S, et al. Is insulin lispro safe in pregnant women: does it cause any adverse outcomes on infants or mothers? Diabetes Res Clin Pract 2008; 80: 444-448.
331. Lapolla A, DalfràMG, Spezia R, Anichini R, Bonomo M, Bruttomesso D, et al. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetol 2008; 45: 61-66.
332. Durnwald CP, Landon MB. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. J Matern Fetal Neonatal Med 2008; 21: 309-313.
333. Hirsch IB. Insulin analogues. N Engl J Med 2005; 352: 174-183.
334. Kurtzhals P, Schäffer L, Sørensen A, Kristensen C, Jonassen I, Schmid C, et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000; 49: 999-1005.
335. Gallen IW, Jaap A, Roland JM, Chirayath HH. Survey of glargine use in 115 pregnant women with type 1 diabetes. Diabet Med 2008; 25: 165-169.
336. Price N, Bartlett C, Gillmer M. Use of insulin glargine during pregnancy: a case-control pilot study. Br J Obstet Gynaecol 2007; 114: 453-457.
337. Di Cianni G, Torlone E, Lencioni C, Bonomo M, Di Benedetto A, Napoli A, et al. Perinatal outcomes associated with the use of glargine during pregnancy. Diabet Med 2008; 25: 993-996.
338. Retnakaran R, Hochman J, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V, et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care 2004; 27: 2590-2596.
339. Mukhopadhyay A, Farrell T, Fraser RB, Ola B. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant women with diabetes: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007; 197: 447-456.
340. Farrar D, Tuffnell DJ, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2007; 3:CD005542.
341. Lapolla A, DalfràMG, Masin M, Bruttomesso D, Piva I, Crepaldi C, et al. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol 2003; 40: 143-149.
342. Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 2005; 83: 1575-1578.
343. Hawthorne G. Metformin use and diabetic pregnancy: has its time come? Diabet Med 2006; 23: 223-227.
344. Coetzee EJ. Counterpoint: oral hypoglyemic agents should be used to treat diabetic pregnant women. Diabetes Care 2007; 30: 2980-2982.
345. Ekpebegh CO, Coetzee EJ, van der Merwe L, Levitt NS. A 10-year retrospective analysis of pregnancy outcome in pregestational type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabet Med 2007; 24: 253-258.
346. Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 2006; 86: 658-663.
347. Nicholson W, Bolen S, Witkop CT, Neale D, Wilson L, Bass E. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol 2009; 113: 193-205.
348. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008; 358: 2003-2015.
349. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000; 343: 1134-1138.
350. Hytten FF. Nutrition. In: Hytten E, Chamberlain G, eds. Clinical Physiology in Obstetrics. Oxford, UK: Blackwell Scientific Publications, 1980: 163-192.
351. Bianco A, Smilen SW, Davis Y, Lopez S, Lapinski R, Lockwood CJ. Pregnancy outcome and weight gain recommendations for the morbidly obese woman. Obstet Gynecol 1998; 91: 97-102.
352. Nohr EA, Bech BH, Vaeth M, Rasmussen KM, Henriksen TB, Olsen J. Obesity, gestational weight gain and preterm birth: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol 2007; 21: 5-14.
353. Oken E, Kleinman KP, Belfort MB, Hammitt JK, Gillman MW. Associations of gestational weight gain with short-and longer-term maternal and child health outcomes. Am J Epidemiol 2009; 170: 173-180.
354. Oken E, Rifas-Shiman SL, Field AE, Frazier AL, Gillman MW. Maternal gestational weight gain and offspring weight in adolescence. Obstet Gynecol 2008; 112: 999-1006.
355. Nohr E, Vaeth M, Baker JL, Sørensen TIa, Olsen J, Rasmussen KM. Combined associations of prepregnancy body mass index and gestational weight gain with the outcome of pregnancy. Am J Clin Nutr 2008; 87: 1750-1759.
356. Barboza JM, Dajani NK, Glenn LG, Angtuaco TL. Prenatal diagnosis of congenital cardiac anomalies: a practical approach using two basic views. Radiographics 2002; 22:1125-1137; discussion 1137-1138.
357. Aschwald CL, Catanzaro RB, Weiss EP, Gavard JA, Steitz KA, Mostello DJ. Large-for-gestational-age infants of type 1 mother with diabetes: an effect of preprandial hyperglycemia? Gynecol Endocrinol 2009: 1-8.
358. Raychaudhuri K, Maresh M. Glycemic control throughout pregnancy and fetal growth in insulin-dependent diabetes. Obstet Gynecol 2000; 95: 190-194.
359. Jovanovic-Peterson L, Durak EP, Peterson CM. Randomized trial of diet versus diet plus cardiovascular conditioning on glucose levels in gestational diabetes. Am J Obstet Gynecol 1989; 161: 415-419.
360. Brankston GN, Mitchell BF, Ryan EA, Okun NB. Resistance exercise decreases the need for insulin in overweight women with gestational diabetes mellitus. Am J Obstet Gynecol 2004; 190: 188-193.
361. Balani J, Hyer SL, Rodin DA, Shehata H. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study. Diabet Med 2009; 26: 798-802.
362. Holt RI, Clarke P, Parry EC, Coleman MA. The effectiveness of glibenclamide in women with gestational diabetes. Diabetes Obes Metab 2008; 10: 906-911.
363. Peel J, Oakley W. The management of pregnancy in diabetics. In: Transactions of the 12th British Congress of Obstetrics and Gynaecology. London: Royal College of Obstetricians and Gynaecologists, 1949: 161.
364. Beard RW, Lowy C. The British survey of diabetic pregnancies. Br J Obstet Gynaecol 1982: 89: 783-786.
365. McAuliffe FM, Foley M, Firth R, Drury I, Stronge JM. Outcome of diabetic pregnancy with spontaneous labor after 38 weeks. Ir J Med Sci 1999; 168: 160-163.
366. Conway DL. Obstetric management in gestational diabetes. Diabetes Care 2007; 30 (Suppl 2): 175-179.
367. Kjos SL, Henry OA, Montoro M, Buchanan TA, Mestman JH. Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol 1993; 169: 611-615.
368. Lurie S, Insler V, Hagay ZJ. Induction of labor at 38 to 39 weeks of gestation reduces the incidence of shoulder dystocia in gestational diabetic patients class A2. Am J Perinatol 1996; 13: 293-296.
369. Matsushita E, Matsuda Y, Makino Y, Sanaka M, Ohta H. Risk factors associated with preterm delivery in women with pregestational diabetes. J Obstet Gynaecol Res 2008; 34: 851-857.
370. Lepercq J, Coste J, Theau A, Dubois-Laforgue D, Timsit J. Factors associated with preterm delivery in women with type 1 diabetes: a cohort study. Diabetes Care 2004; 27: 2824-2828.
371. Mathiesen ER, Christensen AB, Hellmuth E, Hornnes P, Stage E, Damm P. Insulin dose during glucocorticoid treatment for fetal lung maturation in diabetic pregnancy: test of an algorithm [correction of analgoritm]. Acta Obstet Gynecol Scand 2002; 81: 835-839.
372. Kaushal K, Gibson JM, Railton A, Hounsome B, New JP, Young RJ. A protocol for improved glycemic control following corticosteroid therapy in diabetic pregnancies. Diabet Med 2003; 20: 73-75.
373. Feldberg D, Dicker D, Samuel N, Peleg D, Karp M, Goldman JA. Intrapartum management of insulin-dependent diabetes mellitus (IDDM) gestants: a comparative study of constant intravenous insulin infusion and continuous subcutaneous insulin infusion pump (CSIIP). Acta Obstet Gynecol Scand 1988; 67: 333-338.
374. Taylor R, Lee C, Kyne-Grzebalski D, Marchall SM, Davison JM. Clinical outcomes of pregnancy in women with type 1 diabetes. Obstet Gynecol 2002; 99: 537-541.
375. Carron Brown S, Kyne-Grzebalski D, Mwnagi B, Taylor R. Effect of management policy upon 120 type 1 diabetic pregnancies: policy decisions in practice. Diabet Med 1999; 16: 573-578.
376. Barrett HL, Morris J, McElduff A. Watchful waiting: a management protocol for maternal glycaemia in the peripartum period. Aust N Z J Obstet Gynecol 2009; 49: 162-167.
377. Grummer-Strawn LM, Mei Z. Does breastfeeding protect against pediatric overweight? Analysis of longitudinal data from the Centers for Disease Control and Prevention Pediatric Nutrition Surveillance System. Pediatrics 2004; 113:e81-86.
378. Gillman MW, Rifas-Shiman SL, Berkey CS, Frazier AL, Rockett HR, Camargo CA Jr. Breast-feeding and overweight in adolescence: within-family analysis [corrected]. Epidemiology 2006; 17: 112-114.
379. Mayer-Davis EJ, Rifas-Shiman SL, Zhou L, Hu FB, Colditz GA, Gillman MW. Breast-feeding and risk for childhood obesity: does maternal diabetes or obesity status matter? Diabetes Care 2006; 29: 2231-2237.
380. Mayer-Davis EJ, Dabelea D, Lamichhane AP, D'Agostino RB Jr, Liese AD, Thomas J, et al. Breast-feeding and type 2 diabetes in the youth of three ethnic groups: the SEARCh for diabetes in youth case-control study. Diabetes Care 2008; 31: 470-475.
381. Plagemann A, Harder T. Breast feeding and the risk of obesity and related metabolic diseases in the child. Metab Syndr Relat Disord 2005; 3: 222-232.
382. Briggs GG, Ambrose PJ, Nageotte MP, Padilla G, Wan S. Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol 2005; 105: 1437-1441.
383. Feig DS, Briggs GG, Koren G. Oral antidiabetic agents in pregnancy and lactation: a paradigm shift? Ann Pharmacother 2007; 41: 1174-1180.
384. O'Sullivan JB, Mahan CM. Criteria for oral glucose tolerance test in pregnancy. Diabetes 1964; 13: 278-285.
385. Damm P, Kühl C, Buschard K, Jakobsen BK, Svejgaard A, Sodoyez-Goffaux F, et al. Prevalence and predictive value of islet cell antibodies in women with gestational diabetes. Diabetic Med 1994; 1994: 558-563.
386. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008; 93: 4774-4779.
387. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25: 1862-1868.
388. Beischer NA, Oats JN, Henry OA, Sheedy MT, Walstab JE. Incidence and severity of gestational diabetes mellitus according to country of birth in women living in Australia. Diabetes 1991; 40 (Suppl 2): 35-38.
389. Henry OA, Beischer NA. Long-term implications of gestational diabetes for the mother. Baillieres Clin Obstet Gynaecol 1991; 5: 461-483.
390. Dornhorst A, Paterson CM, Nicholls JS, Wadsworth J, Chiu DC, Elkeles RS, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med 1992; 9: 820-825.
391. Benjamin E, Winters D, Mayfield J, Gohdes D. Diabetes in pregnancy in Zuni Indian women: prevalence and subsequent development of clinical diabetes after gestational diabetes. Diabetes Care 1993; 16: 1231-1235.
392. Metzger BE, Cho NH, Roston SM, Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 1993; 16: 1598-1605.
393. Löbner K, Knopff A, Baumgarten A, Mollenhauer U, Marienfeld S, Garrido-Franco M, et al. Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006; 55: 792-797.
394. Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M. Gestational diabetes mellitus: clinical predictors and long-term risk of develop ing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 2007; 30: 878-883.
395. Peters RK, Kjos SL, Xiang A, Buchanan TA. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996; 347: 227-230.
396. Buchanan TA, Xiang AH, Kjos SL, Trigo E, Lee WP, Peters RK. Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes 1999; 48: 2430-2436.
397. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 2002; 51: 2796-2803.
398. Kim C, Tabaei BP, Burke R, McEwen LN, Lash RW, Johnson SL, et al. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health 2006; 96: 1643-1648.
399. Hunt KJ, Conway DL. Who returns for postpartum glucose screening following gestational diabetes mellitus? Am J Obstet Gynecol 2008; 198: 404, e1-6.
400. Ferrara A, Peng T, Kim C. Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: a report from the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2009; 32: 269-274.
401. Kim C, Herman WH, Vijan S. Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care 2007; 30: 1102-1106.
402. Holt RI, Goddard JR, Clarke P, Coleman MA. A postnatal fasting plasma glucose is useful in determining which women with gestational diabetes should undergo a postnatal oral glucose tolerance test. Diabet Med 2003; 20: 594-598.
403. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
404. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
405. Kim C, Berger DK, Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care 2007; 30: 1314-1319.